(Verbatim from the application): Ischemic heart disease is the leading cause of death in Western cultures. Ischemia is caused by an imbalance in the heart's consumption of oxygen and the delivery of oxygen by the coronary circulation. Under normal conditions, the heart avoids ischemia by tightly matching myocardial oxygen consumption to coronary blood flow. To date, the mechanistic basis of this matching remains unknown. Many coronary vasodilators have been implicated in this process but conclusions have been confounded by the repeated observation that inhibitors of a single dilator do not impair physiologic adjustments in coronary blood flow. Several recent studies indicate a different paradigm, one in which coronary blood flow is not controlled by a singe vasodilator but by a network of redundant vasodilators. When one vasodilator in this network is inhibited, another increases their contribution such that coronary blood flow is preserved. In this regard, several studies have suggested a link between nitric oxide (NO) and adenosine in moderating coronary blood flow. Specifically, when NO is inhibited, the contribution from adenosine may increase, serving as a mechanism of compensatory vasodilation. The mechanism by which this occurs, however, remains unclear. The application tests the novel idea that NO directly reduces response to adenosine and that, when NO production is inhibited, responses to adenosine are potentiated. We find that, in animals chronically treated with the eNOS inhibitor L-NAME, the contribution of adenosine to metabolic hyperemia is increased. Based on this evidence, we hypothesize that adenosine plays an important role as a compensatory vasodilator when NO production is impaired. This hypothesis will be tested in 3 specific aims. 1) We hypothesize that increased vasodilator sensitivity to adenosine is an important compensatory mechanism that maintains normal coronary blood flow if NO production is chronically impaired. To complete this aim, we will examine coronary blood flow, microvascular diameter, interstitial adenosine concentrations and vascular reactivity to receptor blockade on basal and hyperemic flow I both normal and NO-impaired animals. 2) We hypothesize that adenosine A2a receptor mediated coronary vasodilation is augmented by chronic impairment of NO production. We will test this hypothesis by determining whether the dilation to adenosine A2a receptor stimulation is enhanced in coronary arterioles in vitro. We will assess the specificity of this augmentation by determining if alternative dilator pathways are also augmented by chronic reductions in NO production. (3) We hypothesize that, in the context or chronic impairment of NO production, the increased vasodilatory sensitivity to adenosine is associated with an increased expression of adenosine A2a receptors. We will test this hypothesis by using comparative RT-PCR analysis of individual coronary arterioles and determining if A2a receptors are upregulated without changes in other adenosine signaling molecules. Taken together, these studies will provide a thorough examination of the role and mechanisms of action of adenosine as a compensatory vasodilator during chronic NO impairment. This mechanism may contribute to the ability of the coronary circulation to maintain cardiac perfusion and avoid ischemia during the early stages of coronary artery disease when NO-dependent dilation is compromised.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067303-05
Application #
6779878
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Liang, Isabella Y
Project Start
2001-09-01
Project End
2005-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
5
Fiscal Year
2004
Total Cost
$229,887
Indirect Cost
Name
Medical College of Georgia (MCG)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Schreihofer, Ann M; Mandel, Daniel A; Mobley, Susan C et al. (2007) Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. Am J Physiol Heart Circ Physiol 293:H2543-9
Dorrance, Anne M; Pollock, David M; Romanko, Olga P et al. (2007) A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats. Am J Physiol Regul Integr Comp Physiol 292:R415-22
Prakash, Rajan; Mintz, James D; Stepp, David W (2006) Impact of obesity on coronary microvascular function in the Zucker rat. Microcirculation 13:389-96
D'Angelo, Gerard; Mintz, James D; Tidwell, John E et al. (2006) Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats. Hypertension 48:1109-15
Romanko, Olga P; Stepp, David W (2005) Reduced constrictor reactivity balances impaired vasodilation in the mesenteric circulation of the obese Zucker rat. Am J Physiol Heart Circ Physiol 289:H2097-102
Schreihofer, Ann M; Hair, Clark D; Stepp, David W (2005) Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288:R253-61
D'Angelo, Gerard; Elmarakby, Ahmed A; Pollock, David M et al. (2005) Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 46:806-11
Fulton, David; Harris, M Brennan; Kemp, Bruce E et al. (2004) Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90. Am J Physiol Heart Circ Physiol 287:H2384-93